Cargando…
The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO
Background: A prospective clinical study was conducted to investigate whether two different pharmacotherapy strategies of steroid administration impact hearing preservation in adult patients who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. Methods: Twenty ni...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269171/ https://www.ncbi.nlm.nih.gov/pubmed/34203443 http://dx.doi.org/10.3390/jcm10132868 |
_version_ | 1783720517600018432 |
---|---|
author | Skarzynska, Magdalena B. Kolodziejak, Aleksandra Gos, Elżbieta Skarzynski, Piotr H. |
author_facet | Skarzynska, Magdalena B. Kolodziejak, Aleksandra Gos, Elżbieta Skarzynski, Piotr H. |
author_sort | Skarzynska, Magdalena B. |
collection | PubMed |
description | Background: A prospective clinical study was conducted to investigate whether two different pharmacotherapy strategies of steroid administration impact hearing preservation in adult patients who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. Methods: Twenty nine adult participants were included. Pure tone audiometry was performed before implantation, during processor activation and 12 months after activation. There were three treatment groups: (1) intravenous steroid therapy (standard steroid therapy with dexamethasone administrated intravenously at the dose 0.1 mg/kg body mass twice a day); (2) combined oral and intravenous steroid therapy (extended steroid therapy with dexamethasone administrated intravenously at the dose 0.1 mg/kg b.m. twice a day and prednisone (orally) at the dose 1 mg/kg body mass/24 h), and (3) no steroid therapy (a control group). Patients’ hearing thresholds before implantation were on average 103 dB HL, 89 dB HL, and 93 dB HL, respectively. Results: Deterioration of hearing thresholds was observed in all three patients’ groups. Twelve months after surgery the patients with and without steroid therapy had similar hearing thresholds. Conclusions: The steroid regimen used in this study did not play a significant role in patients with non-functional residual hearing, who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. |
format | Online Article Text |
id | pubmed-8269171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82691712021-07-10 The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO Skarzynska, Magdalena B. Kolodziejak, Aleksandra Gos, Elżbieta Skarzynski, Piotr H. J Clin Med Article Background: A prospective clinical study was conducted to investigate whether two different pharmacotherapy strategies of steroid administration impact hearing preservation in adult patients who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. Methods: Twenty nine adult participants were included. Pure tone audiometry was performed before implantation, during processor activation and 12 months after activation. There were three treatment groups: (1) intravenous steroid therapy (standard steroid therapy with dexamethasone administrated intravenously at the dose 0.1 mg/kg body mass twice a day); (2) combined oral and intravenous steroid therapy (extended steroid therapy with dexamethasone administrated intravenously at the dose 0.1 mg/kg b.m. twice a day and prednisone (orally) at the dose 1 mg/kg body mass/24 h), and (3) no steroid therapy (a control group). Patients’ hearing thresholds before implantation were on average 103 dB HL, 89 dB HL, and 93 dB HL, respectively. Results: Deterioration of hearing thresholds was observed in all three patients’ groups. Twelve months after surgery the patients with and without steroid therapy had similar hearing thresholds. Conclusions: The steroid regimen used in this study did not play a significant role in patients with non-functional residual hearing, who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. MDPI 2021-06-28 /pmc/articles/PMC8269171/ /pubmed/34203443 http://dx.doi.org/10.3390/jcm10132868 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Skarzynska, Magdalena B. Kolodziejak, Aleksandra Gos, Elżbieta Skarzynski, Piotr H. The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO |
title | The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO |
title_full | The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO |
title_fullStr | The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO |
title_full_unstemmed | The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO |
title_short | The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO |
title_sort | clinical effects of steroids therapy in the preserving residual hearing after cochlear implantation with the oticon neuro zti evo |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269171/ https://www.ncbi.nlm.nih.gov/pubmed/34203443 http://dx.doi.org/10.3390/jcm10132868 |
work_keys_str_mv | AT skarzynskamagdalenab theclinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT kolodziejakaleksandra theclinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT goselzbieta theclinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT skarzynskipiotrh theclinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT skarzynskamagdalenab clinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT kolodziejakaleksandra clinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT goselzbieta clinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo AT skarzynskipiotrh clinicaleffectsofsteroidstherapyinthepreservingresidualhearingaftercochlearimplantationwiththeoticonneuroztievo |